Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | CNR2 | P34972 | 5/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.56 |
| ▸ | RELA | Q04206 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | PIM1 | P11309 | 1/20 | 0.55 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | IKBKB | O14920 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL367913 | 1.00 | MGAM (0.68) | MGAMALDH1A1MAPTGAACNR2 | |
| SCHEMBL5788458 | 0.98 | MGAM (0.66) | MGAMALDH1A1MAPTGAACNR2 | |
| SCHEMBL29135887 | 0.98 | MGAM (0.66) | MGAMALDH1A1MAPTGAACNR2 | |
| Hydrochloric Acid SCHEMBL3401098 | 0.98 | MGAM (0.66) | MGAMALDH1A1MAPTGAACNR2 | |
| SCHEMBL5788456 | 0.98 | MGAM (0.66) | MGAMALDH1A1MAPTGAACNR2 | |
| Ammonia Solution, Strong SCHEMBL29239526 | 0.98 | MGAM (0.66) | MGAMALDH1A1MAPTGAACNR2 | |
| SCHEMBL31434313 | 0.98 | MGAM (0.66) | MGAMALDH1A1MAPTGAACNR2 | |
| Hydrochloric Acid SCHEMBL3400880 | 0.98 | MGAM (0.66) | MGAMALDH1A1MAPTGAACNR2 | |
| Thiophene SCHEMBL3425727 | 0.89 | MGAM (0.56) | MGAMALDH1A1MAPTGAACNR2 | |
| Phthalic Acid SCHEMBL30909153 | 0.89 | MGAM (0.66) | MGAMALDH1A1MAPTGAACNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119462501-A | Preparation method of 2-quinolinamide compound promoted by acidic ionic liquid | 内蒙古民族大学 | 2025-02-18 | — | — | CN | claimed |
| US-20230133600-A1 | PHARMACEUTICAL USE OF KETOAMIDE-BASED COMPOUND | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2023-05-04 | — | — | US | claimed |
| EP-4098258-A1 | PHARMACEUTICAL USE OF KETOAMIDE-BASED COMPOUND | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2022-12-07 | — | — | EP | claimed |
| US-20220112177-A1 | KETOAMIDE COMPOUND AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USE THEREOF | FUDAN UNIVERSITY (CN) | 2022-04-14 | — | — | US | claimed |
| US-12636275-B2 | Pharmaceutical use of ketoamide-based compound | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2026-05-26 | — | — | US | disclosed |
| EP-4720043-A1 | SOLID FORM OF A QUINOLINE CARBOXAMIDE COMPOUND | Syngenta Crop Protection AG (CH) | 2026-04-08 | — | — | EP | disclosed |
| EP-4720043-A1 | SOLID FORM OF A QUINOLINE CARBOXAMIDE COMPOUND | Syngenta Crop Protection AG (CH) | 2026-04-08 | — | — | EP | disclosed |
| WO-2026047037-A1 | MICROBIOCIDAL QUINOLINE-AMIDE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2026-03-05 | — | — | WO | disclosed |
| WO-2026047037-A1 | MICROBIOCIDAL QUINOLINE-AMIDE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2026-03-05 | — | — | WO | disclosed |
| WO-2026008511-A1 | MICROBIOCIDAL QUINOLINE-AMIDE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2026-01-08 | — | — | WO | disclosed |
| WO-2025247781-A1 | SOLID FORM OF A QUINOLINE CARBOXAMIDE COMPOUND | SYNGENTA CROP PROTECTION AG (CH) | 2025-12-04 | — | — | WO | disclosed |
| WO-2025247782-A1 | SOLID FORM OF A QUINOLINE CARBOXAMIDE COMPOUND | SYNGENTA CROP PROTECTION AG (CH) | 2025-12-04 | — | — | WO | disclosed |
| US-20220218693-A1 | IMMUNE CHECKPOINT INHIBITOR COMBINATION THERAPY USING QUINOLINE CARBOXAMIDE DERIVATIVE | KABUSHIKI KAISHA YAKULT HONSHA (JP) | 2022-07-14 | — | — | US | disclosed |
| US-20220218693-A1 | IMMUNE CHECKPOINT INHIBITOR COMBINATION THERAPY USING QUINOLINE CARBOXAMIDE DERIVATIVE | KABUSHIKI KAISHA YAKULT HONSHA (JP) | 2022-07-14 | — | — | US | disclosed |
| EP-3854397-A4 | CANCER COMBINATION THERAPY USING QUINOLINE CARBOXAMIDE DERIVATIVE | Kabushiki Kaisha Yakult Honsha (JP) | 2022-07-13 | — | — | EP | disclosed |
| CN-112239425-B | Preparation method of aporphine alkaloid and intermediate thereof | 温州医科大学 | 2022-06-21 | — | — | CN | disclosed |
| CN-112239424-B | Preparation method of aristolochia alkaloids and intermediate thereof | 温州医科大学 | 2022-06-21 | — | — | CN | disclosed |
| US-20220169640-A1 | PRODUCTION METHOD OF QUINOLINECARBOXAMIDE DERIVATIVE OR PRODUCTION INTERMEDIATE THEREOF | KABUSHIKI KAISHA YAKULT HONSHA (JP) | 2022-06-02 | — | — | US | disclosed |
| US-20220112177-A1 | KETOAMIDE COMPOUND AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USE THEREOF | FUDAN UNIVERSITY (CN) | 2022-04-14 | — | — | US | disclosed |
| EP-3960199-A1 | IMMUNE CHECKPOINT INHIBITOR COMBINATION THERAPY USING QUINOLINE CARBOXAMIDE DERIVATIVE | Kabushiki Kaisha Yakult Honsha (JP) | 2022-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220112177-A1 | KETOAMIDE COMPOUND AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USE THEREOF | ACE, REN, ACE2 | MGAM 134/4885ALDH1A1 1463/4885MAPT 766/4885 |
| US-20230133600-A1 | PHARMACEUTICAL USE OF KETOAMIDE-BASED COMPOUND | CTSL, CTSV, CTSS | MGAM 75/4885ALDH1A1 2113/4885MAPT 2343/4885 |
| US-20220169640-A1 | PRODUCTION METHOD OF QUINOLINECARBOXAMIDE DERIVATIVE OR PRODUCTION INTERMEDIATE THEREOF | BCKDK, CBR3, NQO2 | MGAM 1079/4885ALDH1A1 213/4885MAPT 3851/4885 |
| US-12636275-B2 | Pharmaceutical use of ketoamide-based compound | CTSV, CTSL, CTSS | MGAM 616/4885ALDH1A1 2589/4885MAPT 4005/4885 |
| US-20220218693-A1 | IMMUNE CHECKPOINT INHIBITOR COMBINATION THERAPY USING QUINOLINE CARBOXAMIDE DERIVATIVE | STAT3, PDCD1, CD274 | MGAM 3443/4885ALDH1A1 742/4885MAPT 2999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.